We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000629:SZSEPangang Group Vanadium & Titanium Resources Co., Ltd. Analysis

Data as of 2026-03-17 - not real-time

CN¥3.71

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock trades at CNY 3.71, comfortably above its 20‑day (3.94) and 50‑day (3.75) simple moving averages, suggesting a short‑term bullish bias. However, the MACD histogram is negative and the MACD signal line sits above the MACD line, flagging bearish momentum. RSI at 42.7 points to a neutral stance, with no clear overbought pressure. The price is perched near the calculated support of CNY 3.58 and well below the resistance level of CNY 4.32, leaving limited upside in the near term. Trading volume has been on a decreasing trend, eroding the strength of any price moves. Volatility is unusually high at over 60 % on a 30‑day basis, while the computed beta of 0.11 indicates very low market‑wide systematic risk.
On the fundamentals side, revenue has contracted by 31 % year‑over‑year, and the company posted a negative profit margin of –0.5 %. Operating cash flow remains positive at CNY 0.37 bn, but free cash flow is modest and the balance sheet carries a debt‑to‑equity ratio of 1.81, reflecting considerable leverage. Return on equity is negative (‑0.65 %) and ROA is barely positive, underscoring weak profitability. The DCF‑derived fair value of roughly CNY 0.25 is starkly lower than the current market price, yielding an implied upside‑downside of –8.4 % and signaling severe overvaluation. Forward earnings expectations translate to a PE of 53, while the price‑to‑book sits at 2.81, further confirming an expensive valuation relative to peers. The company does not pay dividends, eliminating any yield component for income‑focused investors. The Fear & Greed Index reads “Extreme Greed,” indicating that market sentiment may be overly optimistic despite the weak fundamentals. Overall, the combination of high volatility, deteriorating earnings, and an inflated price tag suggests caution for both short‑ and long‑term investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Price near support with limited upside
  • Bearish MACD momentum
  • Decreasing volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Continued earnings weakness
  • High valuation vs DCF
  • Elevated volatility

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Negative ROE and profit margins
  • Heavy debt load
  • Overvalued price relative to fundamentals

Key Metrics & Analysis

Financial Health

Revenue Growth-31.30%
Profit Margin-0.50%
P/E Ratio53.0
ROE-0.65%
ROA0.23%
Debt/Equity1.81
P/B Ratio2.8
Op. Cash FlowCN¥369.6M
Free Cash FlowCN¥89.4M

Technical Analysis

TrendBullish
RSI42.7
SupportCN¥3.58
ResistanceCN¥4.32
MA 20CN¥3.94
MA 50CN¥3.75
MA 200CN¥3.07
MACDBearish
VolumeDecreasing
Fear & Greed Index81.48

Valuation

Fair ValueCN¥0.25
Target PriceCN¥3.40
Upside/Downside-8.36%
GradeOvervalued
TypeValue

Risk Assessment

Beta0.11
Volatility61.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.